Director/PDMR Shareholding

14th Apr 2026 14:48

RNS Number : 4489A
Weir Group PLC
14 April 2026
 

14 April 2026

 

The Weir Group PLC

 

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them

 

The Weir Group PLC (the "Company") hereby announces that on 13 April 2026, the PDMR noted below was granted deferred bonus awards under The Weir Group Share Reward Plan.

This notification relates to a transaction notified in accordance with the Market Abuse Regulation, further details below:

 

 

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Kristen Walsh

2.

Reason for the notification

a)

Position/status

Division President

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

The Weir Group PLC

b)

LEI

549300KDR56WHY9I3D10

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 12.5p each fully paid

 

GB0009465807

b)

Nature of the transaction

Grant of Deferred Bonus Award under The Weir Group Share Reward Plan. The award will vest in a single tranche on 13 April 2029.

The Award is not subject to performance conditions.

No consideration was paid for the grant of the award.

 c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

2,261

 

 

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

13 April 2026

f)

Place of the transaction

Outside a trading venue

 

For further information, please contact:

 

Jennifer Haddouk

Company Secretary

Telephone: 0141 308 3771

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHIIMJTMTIBBRF